A proposed mechanism for the cardioprotective effect of oestrogen in women: Enhanced endothelial nitric oxide release decreases coronary artery reactivity

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 3, 1996, Pages 260-266

  Wellman, George C ^a   Brayden, Joseph E ^a   Nelson, Mark T ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

coronary arteries; nitric oxide; oestrogen; potassium channels

Indexed keywords

CYCLIC GMP; CYCLIC GMP DERIVATIVE; ESTRADIOL; ESTROGEN; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HUMAN; MALE; NONHUMAN; RAT; SEX DIFFERENCE; VASCULAR ENDOTHELIUM;

EID: 0029888913     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02608.x     Document Type: Conference Paper

References (70)

1. World Health Organization. World Health Statistics Quarterly. World Health Organization, Geneva. 1982.
2. Paganini-Hill A, Ross RK, Henderson BE. Prevalence of chronic disease and health practices in a retirement community. J. Chronic Dis. 1986; 39: 699-707.
3. Bush TL, Barret-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study. Circulation 1987; 75: 1102-9.
4. Stampfer MJ, Colditz GA, Willet WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 1991; 325: 756-62.
5. Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 1991; 265: 1861-7.
6. 2α mediated contraction of the porcine coronary artery. Adv. Prostaglandin Thromboxane Leukot. Res. 1989; 19: 277-80.
7. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br. J. Pharmacol. 1991; 104: 1033-7.
8. Shan J, Resnick LM, Liu Q-Y, Wu X-C, Barbagallo M, Pang PKT. Vascular effects of 17β-estradiol in male Spraque-Dawley rats. Am. J. Physiol. 1994; 266: H967-73.
9. Genuth SM. The reproductive glands. In: Berne RM, Levy M. (eds). Physiology. CV Mosby Co., Washington. 1986; Ch. 55.
10. Lonning PE, Dowsett M, Jacobs S, Schem B, Hardy J, Powles TJ. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. J. Steroid Biochem. 1989; 34: 551-3.
11. 1α by uterine arteries from postmenopausal women. Am. J. Obstetr. Gynecol. 1989; 161: 1677-81.
12. Chang W-C, Nakao J, Orimo H, Murota S-I. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim. Biophys. Acta 1980; 619: 107-18.
13. Seillan C, Ody C, Russo-Marie F, Duval D. Differential effects of sex steroids on prostaglandin secretion by male and female cultured piglet endothelial cells. Prostaglandins 1983; 26: 3-12.
14. Furchgott RF, Khan MT, Jothianandan D. Evidence supporting the proposal that endothelium-derived relaxing factor is nitric oxide (Abstr.). Thromb. Res. 1986; Suppl. VII: 5.
15. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
16. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 1987; 148: 1482-9.
17. Rosselli M, Imthurum B, Macas E, Keller PJ, Dubey RK. Circulating nitrite/nitrate levels increase with follicular development: Indirect evidence for estradiol mediated NO release. Biochem. Biophys. Res. Commun. 1994; 202: 1543-52.
18. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-7.
19. Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Am. Coll. Cardiol. 1994; 24: 1757-61.
20. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 1994; 73: 951-2.
21. Gilligan DM, Quyyumi AA, Cannon RO, Johnson GB, Schenke WH. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-51.
22. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 1988; 244: 19-22.
23. Williams SP, Shackelford DP, Iams SG, Mustafa SJ. Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur. J. Pharmacol. 1988; 145: 205-7.
24. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am. J. Physiol. 1995; 268: H377-83.
25. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-Arginine. Nature 1988; 333: 664-6.
26. Van Buren GA, Yang D, Clark KE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstetr. Gynecol. 1992; 167: 828-33.
27. Hayashi TL, Fukuto JM, Ignarro LI, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc. Natl Acad. Sci. USA 1992; 89: 11 259-63.
28. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from rat aortae. Am. J. Physiol. 1994; 268: H2311-17.
29. Keaney JF, Shwaery GT, Xu A et al. 17-β Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994; 89: 2251-9.
30. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978; 201: 817-19.
31. Leiberman JR, van Vroonhoven CJ, Beckman I, van der Kwast TH, Wallenburg HCS. Uterine artery estrogen receptors in the nonpregnant and pregnant guinea pig. Am. J. Obstet. Gynecol. 1990; 163: 1685-8.
32. Oursler MJ, Landers JP, Riggs BL, Speisberg TC. Oestrogen effects on osteoblasts and osteoclasts. Ann. Med. 1993; 25: 361-71.
33. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl Acad. Sci. USA 1994; 91: 5212-16.
34. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun. 1994; 205:905-10.
35. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol. Rev. 1990; 70: 921-53.
36. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J. Physiol. (London) 1902; 28: 220-31.
37. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann. Biomed. Eng. 1984; 12: 463-79.
38. Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ. Res. 1984; 55: 197-202.
39. Brayden JE, Wellman GC. Endothelium-dependent dilation of feline cerebral arteries: Role of membrane potential and cyclic nucleotides. J. Cereb. Blood Flow Metab. 1989; 9: 256-63.
40. Speden RN. Electrical activity of single smooth muscle cell of the mesenteric artery produced by splanchnic nerve stimulation in the guinea pig. Nature 1964; 202: 193-4.
41. Neild TO, Keef K. Measurements of the membrane potential of arterial smooth muscle in anesthetized animals and its relationship to changes in artery diameter. Microvasc. Res. 1985; 30: 19-28.
42. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and the voltage-dependence of arterial smooth muscle tone. Am. J. Physiol. 1990; 259: C3-18.
43. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl Acad. Sci. USA 1977; 74: 3203-7.
44. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Coronary arterial relaxation and guanylate cyclase activation by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cyclic Nucl. Res. 1979; 5: 211-24.
45. Furchgott RF, Zawadzki JV, Cherry PD. Role of the endothelium in the vasodilator response to acetylcholine. In: Vanhoutte P, Leusen I (eds). Vasodilation. Raven Press, New York. 1981; 49-66.
46. Lincoln TM, Komalavilas P, Cornwell TL. Pleitropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 1994; 23: 1141-9.
47. Popescu LM, Panoui C, Hinescu M, Nuto O. The mechanism of cGMP-induced relaxation in vascular smooth muscle. Eur. J. Pharmacol. 1985; 107: 393-4.
48. ++-ATPase by cGMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 1987; 84: 5685-9.
49. ++ by sarcoplasmic reticulum in vascular smooth muscle. Circ. Res. 1988; 62: 961-4.
50. Lincoln TM, Cornwall TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 1991; 28: 129-37.
51. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 1995; 268: C799-822.
52. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256: 532-5.
53. + channels in vasodilation induced by nitroglycerin, acetylcholine and nitric oxide. J. Pharmacol. Exp. Ther. 1993; 267: 1327-35.
54. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 1994; 91: 7583-7.
55. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol. 1993; 265: C299-303.
56. Hille B. Ion Channels of Excitable Membranes. Sinauer Press, Sunderland, MA. 1992.
57. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pfluegers Arch. 1993; 463: 167-72.
58. + channels in vascular smooth muscle cells. Proc. Natl Acad Sci. USA 1988; 85: 9360-4.
59. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates potassium channels in vascular smooth muscle. Nature 1994; 368: 850-3.
60. McCarron JG, Osol G, Halpern W. Myogenic responses are independent of the endothelium in rat pressurized posterior cerebral arteries. Blood Vessels 1989; 26: 315-19.
61. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am. J. Physiol. 1990; 259: H668-73.
62. Nelson MT, Standen NB, Brayden JE, Worley JF. Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature 1988; 336: 382-5.
63. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric-oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA 1989; 86: 3375-8.
64. Haynes WG, Noon JP, Walker BR, Webb DJ. L-NMMA increases blood pressure in man. Lancet 1993; 342: 931-2.
65. Daut J, Standen NB, Nelson MT. The role of the membrane potential of endothelial and smooth muscle cells in the regulation of coronary blood flow. J. Cardiovasc. Electrophysiol. 1994; 5: 154-81.
66. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 1990; 66: 1561-75.
67. Amezcua JL, Palmer RMJ, de Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol. 1989; 97: 1119-24.
68. Humphries RG, Carr RD, Nicol AK, Tomlinson W, O'Connor SE. Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-N-nitro arginine. Br. J. Pharmacol. 1991; 102: 1033-7.
69. Jones LF, Brody MJ. Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J. Pharmacol. Exp. Ther. 1992; 260:627-31.
70. Dunn WR, Wellman GC, Bevan JA. Enhanced resistance artery sensitivity to agonists under isobaric conditions compared with isometric conditions. Am. J. Physiol. 1994; 266: H147-55.